logo
Brazilian meat giant JBS gets closer to listing on the NYSE—despite ‘history of corruption'

Brazilian meat giant JBS gets closer to listing on the NYSE—despite ‘history of corruption'

Fast Company23-05-2025

Brazilian meat giant JBS came a step closer Friday to its long-held goal of trading its shares on the New York Stock Exchange.
The company's minority shareholders voted to approve the company's plan to list its shares both in Sao Paulo and New York, casting aside opposition from environmental groups, U.S. lawmakers and others who noted JBS' record of corruption, monopolistic behavior and environmental destruction.
JBS Global CEO Gilberto Tomazoni said the outcome showed shareholders were confident in the benefits a dual listing would bring. The company said before the vote that listing shares in the U.S. would boost its global profile and attract new investors.
JBS said it expected to begin trading on the New York Stock Exchange on June 12. The U.S. Securities and Exchange Commission granted the company's request to list its shares in New York late last month.
JBS is one of the world's largest food companies, with more than 250 production facilities in 17 countries. Half of its annual revenue comes from the U.S., where it has more than 72,000 employees. It's America's top beef producer and it's second-largest producer of poultry and pork.
JBS's plan—which has been in the works for years—has generated significant pushback.
Last fall, 20 environmental organizations—including Mighty Earth, Greenpeace and Rainforest Action Network—signed an open letter to JBS investors opposing the listing, saying it would put the climate at greater risk.
Glass Lewis, an influential independent investor advisory firm, was also among those recommending that shareholders reject the plan.
In its report, Glass Lewis said the recent return of brothers Joesley and Wesley Batista to the JBS board should concern investors. The brothers, who are the sons of JBS' founder, were briefly jailed in Brazil in 2017 on bribery and corruption charges.
'In our view, the involvement of the company and of Joesley and Wesley Batista in multiple high-profile scandals has tarnished the company's reputation, undermining stakeholder trust and posing a significant risk to its competitive position,' Glass Lewis said.
Glass Lewis also objected to the company's plan for dual share classes, which would give the Batistas and other controlling shareholders more voting power.
In its response to Glass Lewis' report, JBS said it has established more stringent controls and anti-corruption training at the company in recent years. It also said a U.S. listing would ensure more oversight from U.S. authorities.
'We believe this transaction will increase our visibility in global markets, attract new investors and further strengthen our position as a global food industry leader,' Tomazoni said in a statement last month when the company announced Friday's vote.
Many U.S. lawmakers also aren't convinced JBS belongs on the New York Stock Exchange.
In a letter sent last week to JBS, U.S. Sen. Elizabeth Warren, a Massachusetts Democrat, noted that Pilgrim's Pride —a U.S. company owned by JBS—was the largest single donor to President Donald Trump's inaugural committee, with a $5 million gift. The SEC's approval came just weeks after that donation, Warren said.
'I am concerned Pilgrim's Pride may have made its contribution to the inaugural fund to curry favor with the Trump administration,' Warren wrote in the letter, which asked the company why the donation was made.
In a statement, JBS said it has a 'long bipartisan history of participating in the civic process.'
Warren was also among a bipartisan group of 15 U.S. senators who sent a letter to the SEC in January 2024 urging the agency to reject a U.S. listing for JBS. The senators, a diverse group that rarely agrees on policy, included Republicans Marco Rubio of Florida and Josh Hawley of Missouri, Democrat Cory Booker of New Jersey and Independent Bernie Sanders of Vermont.
The letter noted that in 2020, J&F Investments, a controlling shareholder of JBS that is owned by the Batista family, pleaded guilty to bribery charges in U.S. federal court and agreed to pay fines of $256 million.
It also said Pilgrim's Pride pleaded guilty to price-fixing charges in 2021. And it said U.S. Senate investigations found that JBS is 'turning a blind eye' to rainforest destruction in the Amazon by its suppliers.
'Approval of JBS' proposed listing would subject U.S. investors to risk from a company with a history of blatant, systemic corruption, and further entrench its monopoly power and embolden its monopoly practices,' the letter said.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

The Deal: Magic Johnson
The Deal: Magic Johnson

Bloomberg

time16 minutes ago

  • Bloomberg

The Deal: Magic Johnson

In this episode of The Deal, Alex Rodriguez and Jason Kelly talk with Magic Johnson, the iconic point guard for the Los Angeles Lakers. In their conversation, taped in front of a live audience at the Milken Global Conference, Johnson reveals what he's learned from his 'greatest deal,' becoming part of the Washington Commanders ownership group. He also explains why pitching himself as a partner to the Starbucks board was the hardest thing he's ever done, and how much it meant to win an Olympic gold medal alongside Michael Jordan and Larry Bird.

States sue to block the sale of genetic data collected by DNA testing company 23andMe
States sue to block the sale of genetic data collected by DNA testing company 23andMe

Yahoo

time17 minutes ago

  • Yahoo

States sue to block the sale of genetic data collected by DNA testing company 23andMe

Dozens of states have filed a joint lawsuit against the bankrupt DNA-testing company 23andMe to block the company's sale of its customers' genetic data without explicit consent. The suit, filed this week in U.S. Bankruptcy Court in the Eastern District of Missouri, comes months after 23andMe began a court-supervised sale process of its assets. The South San Francisco-based venture was once valued at $6 billion and has collected DNA samples from more than 15 million customers. The company's bankruptcy has raised questions over privacy standards for genetic data, which experts say is uniquely sensitive, immutable and irreplaceable if stolen. Twenty-seven states and the District of Columbia filed the lawsuit, arguing that 23andMe customers have an inherent right to their own genetic information. Read more: 'People should be worried': 23andMe bankruptcy could expose customers' genetic data 'This isn't just data — it's your DNA," said Oregon Atty. Gen. Dan Rayfield in a statement. "It's personal, permanent, and deeply private. People did not submit their personal data to 23andMe thinking their genetic blueprint would later be sold off to the highest bidder." 23andMe announced in May that it would be sold to New York-based drug maker Regeneron Pharmaceuticals, which had agreed to comply with 23andMe's existing privacy policy. However, a competing offer from nonprofit TTAM Research Institute led the bankruptcy judge to reopen the auction last week. TTAM is run by 23andMe co-founder Anne Wojcicki, who has made several failed attempts to take the company private. In a statement, a 23andMe spokesperson said the lawsuit's claims "are without merit" and that the sale of genetic data does not violate privacy regulations. 'Customers will continue to have the same rights and protections in the hands of the winning bidder," the spokesperson said. Read more: Congressmen sound alarm over data privacy following 23andMe bankruptcy 23andMe customers have the right to delete their genetic information from the company's database at any time, as outlined in the Genetic Information Privacy Act and the California Consumer Privacy Act. During a testimony in Washington earlier this week, 23andMe interim Chief Executive Joseph Selsavage said that 1.9 million customers have requested their data be deleted since the company's bankruptcy filing in March. Sara Geoghegan, senior counsel at the Electronic Privacy Information Center, said that 23andMe's privacy policy was subject to change and not adequate to protect customers' data. In an interview in March, she stressed the sensitivity of genetic data. 'I would be very concerned if I had given a swab to 23andMe," she said. "There is little we can do to control what happens to it." Sign up for our Wide Shot newsletter to get the latest entertainment business news, analysis and insights. This story originally appeared in Los Angeles Times.

US Inflation Beats Estimates for a Fourth Month
US Inflation Beats Estimates for a Fourth Month

Bloomberg

time19 minutes ago

  • Bloomberg

US Inflation Beats Estimates for a Fourth Month

For four months many economists have predicted that US inflation would reignite, in large part due to President Donald Trump's trade war and the knock-on effects his tariffs would have on the economy. But for a fourth month in a row, data released by the Trump administration's Bureau of Labor Statistics came in lower than expected. The consumer price index, excluding the often volatile food and energy categories, increased only 0.1% from April, according to government data. The string of below-forecast inflation readings could be attributable to how many of the administration's threatened levies are on hold. (In early April, Trump's 'reciprocal' tariffs managed to destabilize the bond market before he largely retreated.) Treasury Secretary Scott Bessent, who is being floated as a potential replacement for Jerome Powell at the Federal Reserve, credited Trump's trade policies for slowing inflation, saying he challenged a 'decades-old status quo.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store